Biosafety biosecurity measures during the care of dental patients in COVID-19 pandemic
DOI:
https://doi.org/10.35381/s.v.v6i2.2137Keywords:
Coronavirus Infections, Severe Acute Respiratory Syndrome, Dental Care. (Source, DeCS).Abstract
Objective: To analyze the biosecurity measures during the care of dental patients in the COVID-19 pandemic. Method: Descriptive documentary with bibliographic analysis. Results: The use of Chlorhexidine could be used to mitigate the appearance of the virus, but it would not be effective in the elimination of SarsCov 2, once it has been acquired by the individual. Conclusion: To take into account the symptomatology corresponding to COVID-19 without leaving aside the asymptomatic cases, in order to consider the need to perform serologies, in addition to making use of adequate mouthwash alternatives to reduce viral loads and the responsibility with our patients with the application of COVID-19 test to the personnel before, during and after returning to work.
Downloads
References
Plourde AR, Bloch EM. A Literature Review of Zika Virus. Emerg Infect Dis. 2016;22(7):1185-1192. doi:10.3201/eid2207.151990
Lyons DM, Lauring AS. Mutation and Epistasis in Influenza Virus Evolution. Viruses. 2018;10(8):407. Published 2018 Aug 3. doi: 10.3390/v10080407
Simmonds P, Aiewsakun P. Virus classification - where do you draw the line?. Arch Virol. 2018;163(8):2037-2046. doi:10.1007/s00705-018-3938-z
Wigginton KR, Kohn T. Virus disinfection mechanisms: the role of virus composition, structure, and function. Curr Opin Virol. 2012;2(1):84-89. doi:10.1016/j.coviro.2011.11.003
Poirier EZ, Vignuzzi M. Virus population dynamics during infection. Curr Opin Virol. 2017;23:82-87. doi:10.1016/j.coviro.2017.03.013
Ghosh S, Bornman C, Zafer MM. Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?. J Infect Public Health. 2021;14(5):555-560. doi:10.1016/j.jiph.2021.02.011
Canouï E, Launay O. Histoire et principes de la vaccination [History and principles of vaccination]. Rev Mal Respir. 2019;36(1):74-81. doi:10.1016/j.rmr.2018.02.015
Francis MJ. Recent Advances in Vaccine Technologies. Vet Clin North Am Small Anim Pract. 2018;48(2):231-241. doi:10.1016/j.cvsm.2017.10.002
Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol. 2020;85:104502. doi:10.1016/j.meegid.2020.104502
Malik YA. Properties of Coronavirus and SARS-CoV-2. Malays J Pathol. 2020;42(1):3-11.
van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368-373. doi:10.1038/nm1024
Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: a syndemic complicated by COVID-19. Diabetes y tuberculosis: una sindemia complicada por la COVID-19. Med Clin (Barc). 2021;157(6):288-293. doi:10.1016/j.medcli.2021.04.004
Moreno-Noguez M, Rivas-Ruiz R, Roy-García IA, Pacheco-Rosas DO, Moreno-Espinosa S, Flores-Pulido AA. Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population. Factores de riesgo asociados con neumonía por SARS-CoV-2 en población pediátrica. Bol Med Hosp Infant Mex. 2021;78(4):251-258. doi:10.24875/BMHIM.20000263
Chen MH, Chang PC. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence. J Formos Med Assoc. 2022;121(5):879-885. doi:10.1016/j.jfma.2021.10.001
Mateos-Moreno MV, Mira A, Ausina-Márquez V, Ferrer MD. Oral antiseptics against coronavirus: in-vitro and clinical evidence. J Hosp Infect. 2021;113:30-43. doi:10.1016/j.jhin.2021.04.004
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
